500 related articles for article (PubMed ID: 16974212)
1. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
Chemaly RF; Ghosh S; Bodey GP; Rohatgi N; Safdar A; Keating MJ; Champlin RE; Aguilera EA; Tarrand JJ; Raad II
Medicine (Baltimore); 2006 Sep; 85(5):278-287. PubMed ID: 16974212
[TBL] [Abstract][Full Text] [Related]
2. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study.
Atilla E; Sahin D; Atilla PA; Dolapci I; Tekeli A; Bozdag SC; Yuksel MK; Toprak SK; Ilhan O; Arslan O; Ozcan M; Gurman G; Topcuoglu P
Antivir Ther; 2018; 23(6):523-527. PubMed ID: 29424696
[TBL] [Abstract][Full Text] [Related]
3. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.
Chemaly RF; Shah DP; Boeckh MJ
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S344-51. PubMed ID: 25352629
[TBL] [Abstract][Full Text] [Related]
4. Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea.
Hong KW; Choi SM; Lee DG; Cho SY; Lee HJ; Choi JK; Kim SH; Park SH; Choi JH; Yoo JH; Lee JW
Yonsei Med J; 2017 Mar; 58(2):362-369. PubMed ID: 28120567
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
6. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.
El Chaer F; Shah DP; Kmeid J; Ariza-Heredia EJ; Hosing CM; Mulanovich VE; Chemaly RF
Cancer; 2017 Jun; 123(12):2329-2337. PubMed ID: 28178369
[TBL] [Abstract][Full Text] [Related]
7. Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation.
Hutspardol S; Essa M; Richardson S; Schechter T; Ali M; Krueger J; Fujii H; Egeler RM; Gassas A
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1802-7. PubMed ID: 26117558
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.
Nichols WG; Gooley T; Boeckh M
Biol Blood Marrow Transplant; 2001; 7 Suppl():11S-15S. PubMed ID: 11777098
[TBL] [Abstract][Full Text] [Related]
9. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.
Fontana L; Strasfeld L
Infect Dis Clin North Am; 2019 Jun; 33(2):523-544. PubMed ID: 30940462
[TBL] [Abstract][Full Text] [Related]
10. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections.
Dykewicz CA; ; ;
Biol Blood Marrow Transplant; 2001; 7 Suppl():19S-22S. PubMed ID: 11777100
[TBL] [Abstract][Full Text] [Related]
13. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
von Lilienfeld-Toal M; Berger A; Christopeit M; Hentrich M; Heussel CP; Kalkreuth J; Klein M; Kochanek M; Penack O; Hauf E; Rieger C; Silling G; Vehreschild M; Weber T; Wolf HH; Lehners N; Schalk E; Mayer K
Eur J Cancer; 2016 Nov; 67():200-212. PubMed ID: 27681877
[TBL] [Abstract][Full Text] [Related]
14. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
Renaud C; Xie H; Seo S; Kuypers J; Cent A; Corey L; Leisenring W; Boeckh M; Englund JA
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1220-6. PubMed ID: 23680472
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.
Martino R; Porras RP; Rabella N; Williams JV; Rámila E; Margall N; Labeaga R; Crowe JE; Coll P; Sierra J
Biol Blood Marrow Transplant; 2005 Oct; 11(10):781-96. PubMed ID: 16182179
[TBL] [Abstract][Full Text] [Related]
16. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.
Lo MS; Lee GM; Gunawardane N; Burchett SK; Lachenauer CS; Lehmann LE
Pediatr Transplant; 2013 Mar; 17(2):133-43. PubMed ID: 23228170
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
18. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
Nichols WG; Corey L; Gooley T; Davis C; Boeckh M
Blood; 2001 Aug; 98(3):573-8. PubMed ID: 11468152
[TBL] [Abstract][Full Text] [Related]
19. Viral infections in immunocompromised patients: what's new with respiratory viruses?
Ison MG; Hayden FG
Curr Opin Infect Dis; 2002 Aug; 15(4):355-67. PubMed ID: 12130931
[TBL] [Abstract][Full Text] [Related]
20. Respiratory virus infections in stem cell transplant patients: the European experience.
Ljungman P
Biol Blood Marrow Transplant; 2001; 7 Suppl():5S-7S. PubMed ID: 11777102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
